Revisiting Atopic March: Clinical Overview and Treatment Options Dr. Kamal Kant Kohli22 April 2023 11:44 AM ISTAtopic March was first described more than 20 years ago as "the natural history of atopic manifestations, characterized by a typical sequence of...
Managing Atopic Diseases across Age Group Dr. Kamal Kant Kohli27 Feb 2023 11:30 AM ISTAtopy is a genetic tendency to produce high IgE antibodies in response to common allergens, which increases the risk of developing atopic illnesses...
United Airway Disease and Clinical Applicability of Montelukast Fexofenadine Combination: Review Dr. Kamal Kant Kohli20 Oct 2022 12:30 PM ISTRecent epidemiological, pathophysiological, and clinical scientific evidence has identified a relationship between upper and lower respiratory...
Respiratory Allergies in India and Clinical Review of Montelukast Fexofenadine Combination in its Management Dr. Kamal Kant Kohli24 Sept 2022 11:57 AM ISTAllergic respiratory diseases (ARDs) are caused by the production of IgE antibodies to airborne allergens, causing various clinical manifestations in...
53 Drug Samples Fail To Clear CDSCO Test, 1 Declared Misbranded Susmita Roy12 Aug 2022 6:00 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 53 medicine...
Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection Dr. Kamal Kant Kohli19 May 2022 12:54 PM ISTThe spiking frequency of allergic respiratory illness over the last several decades, and the increasing rate of air pollution owing to urbanization,...
Combatting allergic rhinitis-Why prefer Fexofenadine - Montelukast over Bilastine-Montelukast? dr. Abhimanyu Uppal9 Nov 2021 12:31 PM ISTWith the COVID restrictions getting unlocked in almost all states of India along with the approaching season of allergies, physicians across the...
Physician's choice of antihistaminic-leukotriene antagonist combination: An evidence-based comparison of montelukast-fexofenadine versus montelukast- levocetirizine dr. Abhimanyu Uppal8 Sept 2021 12:12 PM ISTNew Delhi: The pandemic restrictions are unlocking amid the looming fear of a 3rd COVID wave at this year's end. Physicians need to be aware and...
New updates in COVID-19 research: Emerging therapeutic role of Fexofenadine and Montelukast. dr. Abhimanyu Uppal10 July 2021 11:17 AM ISTThe dawn of the year 2020 witnessed the surge of one of the biggest pandemics known to mankind. COVID-19 spread through continents affecting millions...
Ind-Swift Labs launches anti-allergic drug Fexofenadine in US Ruchika Sharma17 Jun 2020 2:49 PM ISTFexofenadine is an AntiHistamine Drug used for the treatment of seasonal allergic rhinitis and Urticaria in US market.
Antenatal Fexofenadine not linked to risk of abortion or premature birth Dr. Kamal Kant Kohli4 Jun 2020 4:41 PM ISTA new JAMA study has revealed that Fexofenadine use during pregnancy was not linked with birth defects or spontaneous abortion. Antihistamines are one...
